INVITATION

 

Greetings from the International Vaccine Institute (IVI), and the RADAAR Project.

 

As a key policy stakeholder contributing to AMR containment efforts, we invite you to participate and share your views and insights at a bi-regional (Asia and Africa) AMR Policy Workshop, organized by the RADAAR Project consortium which is led by the International Vaccine Institute (IVI), Seoul, Korea.

 

As the only Fleming Fund regional AMR project fully dedicated to the thematic domain of ‘Policy, Planning, and Advocacy’, and building on the highly successful previous RADAAR events including the Regional Data Workshops (June – July 2021) and ‘The Gamechangers’ series of 6 policy webinars (Sept – Oct 2021), this Policy Workshop responds to the priority topics and needs expressed by national/regional/global AMR stakeholders through the RADAAR Online Survey and Key Informant Interviews.

 

The workshop will have a series of sessions covering various key topics including: re-thinking mechanisms of AMR emergence and spread; integrated (One Health) analysis; approaches to AMR economic analyses; integrated surveillance systems; AMR workforce development; policy implications arising from the GRAM, CAPTURA, and MAAP projects; reflections on mobilizing resources for national AMR interventions; and the systematic translation of AMR data/evidence into policy briefs.  

 

The workshop will be held virtually from 12-14 April 2022 through the Zoom platform, every day at these times: Seoul 5:00-8:00PM | London 9:00AM-12:00PM | Geneva 10:00AM-1:00PM | Nairobi 11:00AM-2:00PM | Bangkok 3:00-6:00PM

 

Workshop Goal: To contribute to strengthening capacities for evidence-informed AMR policy-making, in support of National Action Plan implementation.

 

Specific Objectives:

1.      To share and discuss insights, experiences, and current thinking on policy-relevant issues impacting AMR policymaking.

2.      To advance understanding and knowledge on approaches, analyses, methodologies, and national/regional engagement, towards strengthening capacities for evidence-informed AMR policymaking.

Expected Outcomes:

1.      Improved understanding among participants of current thinking on policy options for AMR containment.

2.      Enhanced knowledge and a demand for capacity-strengthening in translating AMR surveillance data and evidence into effective policy pitches. 

 

A link to participate will be shared with you once you register for the workshop. We kindly request you to confirm your participation by 7 April 2022, by registering your interest through this link:

 

 

The agenda for the 3-day workshop is appended below. All times shown are Korea Standard Time (KST).

 

Time

Program

Speaker/Presenter

Day 1 | 12 April 2022

17:00 – 17:10

Welcome and introduction to workshop agenda

Satyajit Sarkar, IVI

Session 1: Re-thinking the drivers of AMR emergence and spread

Moderator: Dr David Aanensen, Big Data Institute, Oxford University

17:10 – 17:40

Keynote Address

Prof Peter Collignon, Australian National University

17:40 – 18:00

Moderated discussion/Q&A

PLENARY

Session 2: One Health ‘Integrated Analysis’: Challenges and Options for LMICs

Moderator: Dr Olafur Valsson, OIE

18:00 – 18:30

Presentation on exemplar of One Health ‘Integrated Analysis’ in Europe, and the challenges and options for LMICs

Dr Gerard Moulin, ANSES, France

18:30 – 18:50

Moderated discussion/Q&A

PLENARY

Session 3: Brief Informational Sessions

Hosts: Holy Akwar and Satyajit Sarkar, IVI

18:50 – 19:10

Presentation: Tripartite Integrated System for Surveillance on AMR/AMU (TISSA)

Dr Arno Muller, WHO

19:10 – 19:20

Q&A

PLENARY

19:20 – 19:40

Presentation: Qualifying the Workforce for AMR Surveillance in Africa and Asia (QWARS)

Anafi Mataka, ASLM

19:40 – 19:50

Q&A

PLENARY

19:50 – 20:00

Day-1 wrap-up and evaluation poll

Satyajit Sarkar, IVI (PLENARY)

Day 2 | 13 April 2022

17:00 – 17:05

Overview of Day-2 agenda

Satyajit Sarkar, IVI

Session 1: Panel discussion: Policy Implications and Recommendations from the GRAM, CAPTURA, and MAAP Projects

Moderator: Prof Sabiha Essack, University of KwaZulu-Natal and Vice Chair WHO STAG-AMR

17:05 – 17:25

Presentation: Findings from the Global Research on Antimicrobial Resistance (GRAM) project

Dr Catrin Moore, St George’s, University of London

17:25 – 17:45

Presentation: Findings from the Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia (CAPTURA) project

Dr Marianne Holm, IVI

17:45 – 18:05

Presentation: Findings from the Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project

Dr Pascale Ondoa, ASLM

18:05 – 18:30

Moderated discussion/Q&A

PLENARY

Session2: REFLECTIONS: Mobilizing Domestic Resources for AMR Interventions

Moderator: Tom Pilcher, Fleming Fund, DHSC, UK

18:30 – 18:45

Country perspective

Dr Nithima Sumpradit, MOPH, Thailand

18:45 – 19:00

International independent network perspective

Dr Mirfin Mpundu, ReAct Africa

19:00 – 19:15

Regional perspective

Dr Yewande Alimi, African Union/CDC

19:15 – 19:30

Fund Manager perspective

Patrick Mubangizi, Mott Macdonald (E&S Africa Region)

19:30 – 19:50

Moderated discussion/Q&A

PLENARY

19:50 – 20:00

Day-2 wrap-up and evaluation poll

Satyajit Sarkar, IVI (PLENARY)

Day 3 | 14 April 2022

17:00 – 17:05

Overview of Day-3 agenda

Satyajit Sarkar, IVI

Session 1: More than Just About Money: A Journey from Patient to Policymaker

Moderator: Dr Katinka de Balogh, FAO-HQ

17:05 – 17:35

Presentation on economic concepts and analyses to support effective AMR policymaking

Dr Nichola Naylor, LSHTM

17:35 – 18:00

Moderated discussion/Q&A

PLENARY

Session 2: Strengthening Country Capacities to Translate AMR Data and Evidence into Effective Policies

Host: Satyajit Sarkar, IVI

18:00 – 18:10

Introduction and ‘soft launch’ of RADAAR (IVI) and EVIPNet (WHO) collaborative initiative

Satyajit Sarkar, IVI

18:10 – 19:50

Introduction to the EVIPNet approach, methodology, and country engagement activities, for strengthening country capacities for translating AMR evidence-to-policy

Tanja Kuchenmüller, WHO,

and EVIPNet team

19:50 – 20:00

Workshop wrap-up and Day-3 evaluation poll

Satyajit Sarkar, IVI (PLENARY)

 

Biographies of all Speakers and Moderators will be made available to participants in the coming days, and prior to the workshop.

Please forward this invitation to others who may be interested in, or benefit from, this workshop.

 

We look forward to your active participation.

 

 

On behalf of the RADAAR Consortium,

Satyajit Sarkar

Principal Investigator, Project Coordinator, and Policy & Advocacy Technical Lead (RADAAR)

International Vaccine Institute (IVI), Seoul, Korea

Email :  [log in to unmask]

Website : https://www.ivi.int/what-we-do/disease-areas/amr/radaar/

 

 

 

 

 

 



Notice: Information in this e-mail is intended for the exclusive use of the individual or entity named above and may constitute information that is privileged or confidential or otherwise protected from disclosure; its contents do not constitute a commitment by the International Vaccine Institute except where provided for in a written agreement between you and the institute. Any unauthorized disclosure, use or dissemination, either whole or partial, is prohibited. If you are not the intended recipient of this message, please delete the message and notify the sender immediately. Thank you for your cooperation.

 



Notice: Information in this e-mail is intended for the exclusive use of the individual or entity named above and may constitute information that is privileged or confidential or otherwise protected from disclosure; its contents do not constitute a commitment by the International Vaccine Institute except where provided for in a written agreement between you and the institute. Any unauthorized disclosure, use or dissemination, either whole or partial, is prohibited. If you are not the intended recipient of this message, please delete the message and notify the sender immediately. Thank you for your cooperation.

 



Notice: Information in this e-mail is intended for the exclusive use of the individual or entity named above and may constitute information that is privileged or confidential or otherwise protected from disclosure; its contents do not constitute a commitment by the International Vaccine Institute except where provided for in a written agreement between you and the institute. Any unauthorized disclosure, use or dissemination, either whole or partial, is prohibited. If you are not the intended recipient of this message, please delete the message and notify the sender immediately. Thank you for your cooperation.

 

Virus-free. www.avg.com

 

 



Notice: Information in this e-mail is intended for the exclusive use of the individual or entity named above and may constitute information that is privileged or confidential or otherwise protected from disclosure; its contents do not constitute a commitment by the International Vaccine Institute except where provided for in a written agreement between you and the institute. Any unauthorized disclosure, use or dissemination, either whole or partial, is prohibited. If you are not the intended recipient of this message, please delete the message and notify the sender immediately. Thank you for your cooperation.



To unsubscribe from the VPH-L list, click the following link:
&*TICKET_URL(VPH-L,SIGNOFF);